First Pacific Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$298K Sell
249
-26
-9% -$26.6K 0.04% 157
2026
Q1
$253K Buy
275
+1
+0.4% +$1.01K 0.03% 157
2025
Q4
$295K Sell
274
-20
-7% -$19.1K 0.04% 148
2025
Q3
$224K Sell
294
-3
-1% -$2.23K 0.03% 160
2025
Q2
$232K Buy
297
+108
+57% +$83.9K 0.03% 160
2025
Q1
$156K Buy
189
+42
+29% +$34.9K 0.03% 144
2024
Q4
$114K Buy
147
+17
+13% +$14.1K 0.03% 165
2024
Q3
$115K Hold
130
0.03% 155
2024
Q2
$118K Hold
130
0.03% 136
2024
Q1
$101K Hold
130
0.03% 145
2023
Q4
$75.8K Hold
130
0.02% 161
2023
Q3
$69.8K Buy
130
+14
+12% +$7.21K 0.03% 145
2023
Q2
$54.4K Buy
+116
New +$48.6K 0.02% 146

Other funds holding LLY

First Pacific Financial's LLY Position: Q2 2026 in Review

First Pacific Financial reduced its Eli Lilly (LLY) stake by 9.5% in Q2 2026, selling an estimated $26.6K and leaving 249 shares worth $298K. The position accounts for 0.04% of the portfolio, ranked #157.

First Pacific Financial first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • First Pacific Financial held 249 shares of Eli Lilly worth $298K as of Q2 2026.
  • First Pacific Financial sold 26 Eli Lilly shares in Q2 2026, an estimated $26.6K.
  • Eli Lilly made up 0.04% of First Pacific Financial's portfolio in Q2 2026, its #157 holding.
  • First Pacific Financial first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on First Pacific Financial's 13F filing for Q2 2026, filed 20 Jul 2026.